AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11742880 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/d)
Number of subjects: 22
Study 8976243 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrosurgical vaporization
Number of subjects: 0
Study 8976243 — intervention group
Group type: COMPARATOR
Intervention: Conventional loop resection
Number of subjects: 0
Study 8214733 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzyl alcohol 0.9% in normal saline
Number of subjects: 280
Study 8214733 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine 1% with preservative
Number of subjects: 280
Study 8214733 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 280
Study 8214733 — intervention group
Group type: COMPARATOR
Intervention: Control group (no previous drug injected)
Number of subjects: 280
Study 3446416 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol ointment (1% salbutamol base in white soft paraffin) b.d. for 2 weeks
Number of subjects: 7
Study 3446416 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol slow-release spandets
Number of subjects: 7
Study 3446416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 30857385 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion during sevoflurane anesthesia
Number of subjects: 60
Study 30857385 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion during sevoflurane anesthesia
Number of subjects: 60
Study 28705571 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable interference screw fixation
Number of subjects: 33
Study 28705571 — intervention group
Group type: EXPERIMENTAL
Intervention: All-inside cortical button fixation
Number of subjects: 33
Study 25513965 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of ticagrelor (90 mg/bid) and warfarin
Number of subjects: 296
Study 25513965 — intervention group
Group type: COMPARATOR
Intervention: Triple antithrombosis therapy (clopidogrel + aspirin + warfarin)
Number of subjects: 296
Study 23314164 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 86
Study 23314164 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 86
Study 23314164 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 86
Study 21654092 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk balance exercises in addition to standard trunk flexibility exercises
Number of subjects: 79
Study 21654092 — intervention group
Group type: COMPARATOR
Intervention: Strengthening exercises in addition to standard trunk flexibility exercises
Number of subjects: 79
Study 18486746 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude spinal manipulation (SM)
Number of subjects: 72
Study 18486746 — intervention group
Group type: COMPARATOR
Intervention: Prethrust positioning and joint loading
Number of subjects: 72
Study 18486746 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 72
Study 16537707 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drug (NSAID) use
Number of subjects: 1723
Study 16537707 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory drug (NSAID) non-use
Number of subjects: 1723
Study 15342298 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 0
Study 15342298 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study 11094401 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Process Training (APT)
Number of subjects: 14
Study 11094401 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Injury Education
Number of subjects: 14
Study 9347497 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% diclofenac in 2.5% hyaluronan
Number of subjects: 60
Study 9347497 — intervention group
Group type: COMPARATOR
Intervention: 2.5% hyaluronan
Number of subjects: 60
Study 9347497 — intervention group
Group type: COMPARATOR
Intervention: 3% viscous lidocaine
Number of subjects: 60
Study 8239849 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone, 1000 mg
Number of subjects: 171
Study 8239849 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen, 600 mg four times daily
Number of subjects: 171
Study 8239849 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen plus Misoprostol, 600 mg and 200 micrograms four times daily
Number of subjects: 171
Study 3898700 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.185 mg/kg)
Number of subjects: 90
Study 3898700 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.185 mg/kg) plus droperidol (0.09 mg/kg)
Number of subjects: 90
Study 3898700 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.135 mg/kg) plus droperidol (0.09 mg/kg)
Number of subjects: 90
Study 3898700 — intervention group
Group type: COMPARATOR
Intervention: Control group (Diazepam alone)
Number of subjects: 90
Study 31132765 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app for toothbrushing
Number of subjects: 49
Study 31132765 — intervention group
Group type: COMPARATOR
Intervention: Control group (manual toothbrush without app)
Number of subjects: 49
Study 30356312 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 0
Study 30356312 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27474375 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic prostatectomy
Number of subjects: 326
Study 27474375 — intervention group
Group type: COMPARATOR
Intervention: Radical retropubic prostatectomy
Number of subjects: 326
Study 24599463 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over right DLPFC
Number of subjects: 24
Study 24599463 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (control)
Number of subjects: 24
Study 24599463 — intervention group
Group type: COMPARATOR
Intervention: Cathodal tDCS over homologous contralateral area
Number of subjects: 24
Study 22006202 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 3 mg twice daily
Number of subjects: 507
Study 22006202 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 5 mg twice daily
Number of subjects: 507
Study 22006202 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 10 mg twice daily
Number of subjects: 507
Study 22006202 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 15 mg twice daily
Number of subjects: 507
Study 22006202 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 20 mg/day
Number of subjects: 507
Study 22006202 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 507
Study 19547993 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 40
Study 19547993 — intervention group
Group type: COMPARATOR
Intervention: Pimecrolimus
Number of subjects: 40
Study 18049022 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg/day dipyridamole
Number of subjects: 28
Study 18049022 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/day dipyridamole
Number of subjects: 28
Study 18049022 — intervention group
Group type: COMPARATOR
Intervention: Control (no dipyridamole)
Number of subjects: 28
Study 16218039 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-probe guided revision thyroidectomy (GGRT)
Number of subjects: 25
Study 16218039 — intervention group
Group type: COMPARATOR
Intervention: Conventional revision thyroidectomy (CRT)
Number of subjects: 25
Study 12124485 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic detection of CAD using image registration and voxel to voxel statistical comparisons
Number of subjects: 104
Study 12124485 — intervention group
Group type: COMPARATOR
Intervention: Three expert observers
Number of subjects: 104
Study 11004845 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL) in individuals with chronic silica exposure
Number of subjects: 15
Study 8993092 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 227
Study 8993092 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 227
Study 1618361 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 114
Study 1618361 — intervention group
Group type: COMPARATOR
Intervention: no antihypertensive therapy (control)
Number of subjects: 114
Study 6369816 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP iodine prophylaxis
Number of subjects: 58
Study 6369816 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 30686326 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted reach training with assist-as-needed (RT-AAN)
Number of subjects: 38
Study 30686326 — intervention group
Group type: COMPARATOR
Intervention: Robot-assisted reach training with guidance force (RT-G)
Number of subjects: 38
Study 29272062 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Insulin Treatment (IIT) - glargine/glulisine
Number of subjects: 97
Study 29272062 — intervention group
Group type: COMPARATOR
Intervention: Initial Combined Oral Antidiabetic Drug (COAD) therapy - glimepiride/metformin
Number of subjects: 97
Study 26669628 — intervention group
Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg/day
Number of subjects: 1463
Study 26669628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1463
Study 24450500 — intervention group
Group type: EXPERIMENTAL
Intervention: High whey protein, leucine-enriched supplement (20 g whey protein, 3g total leucine, 150 kcal)
Number of subjects: 19
Study 24450500 — intervention group
Group type: COMPARATOR
Intervention: Iso-caloric milk protein control (6g milk protein)
Number of subjects: 19
Study 22500661 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen hydrolysate 1200 mg/day
Number of subjects: 200
Study 22500661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 20116702 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic laser (4 J/cm² energy density, diode wavelength of 810 nm, output power of 100 mW)
Number of subjects: 30
Study 20116702 — intervention group
Group type: COMPARATOR
Intervention: Standard management (control group)
Number of subjects: 30
Study 17573520 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic tadalafil (10 mg)
Number of subjects: 39
Study 17573520 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic dexamethasone (8 mg)
Number of subjects: 39
Study 17573520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 17573520 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 15964386 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus, tacrolimus, low-dose rabbit antithymocyte globulin, and glucocorticoids
Number of subjects: 31
Study 15964386 — intervention group
Group type: COMPARATOR
Intervention: cyclosporine, mycophenolate mofetil, and glucocorticoids
Number of subjects: 31
Study 12691271 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral-B 3D Excel (D17)
Number of subjects: 74
Study 12691271 — intervention group
Group type: COMPARATOR
Intervention: Colgate Actibrush
Number of subjects: 74
Study 10597853 — intervention group
Group type: EXPERIMENTAL
Intervention: Competition season training in lightweight rowers
Number of subjects: 22
Study 10597853 — intervention group
Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 22
Study 8537277 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomefloxacin 400 mg once daily for 5 days
Number of subjects: 40
Study 8537277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8537277 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomefloxacin
Number of subjects: 40
Study 30506227 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium sodium phosphosilicate paste (NovaMin®)
Number of subjects: 70
Study 30506227 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (1 W, 10 Hz, 85 J/cm2)
Number of subjects: 70
Study 30506227 — intervention group
Group type: COMPARATOR
Intervention: Control-placebo
Number of subjects: 70
Study 27936684 — intervention group
Group type: EXPERIMENTAL
Intervention: Jug n 4 allergen
Number of subjects: 25
Study 26482694 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physical activity (PA)
Number of subjects: 333
Study 26482694 — intervention group
Group type: COMPARATOR
Intervention: Health education promoting successful aging (SA)
Number of subjects: 333
Study 23992515 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium Respimat 5 μg
Number of subjects: 17135
Study 23992515 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium Respimat 2.5 μg
Number of subjects: 17135
Study 23992515 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium HandiHaler 18 μg
Number of subjects: 17135
Study 21127721 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents encoding positive pictures
Number of subjects: 30
Study 21127721 — intervention group
Group type: COMPARATOR
Intervention: Adults encoding positive pictures
Number of subjects: 30
Study 21127721 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents encoding negative pictures
Number of subjects: 30
Study 21127721 — intervention group
Group type: COMPARATOR
Intervention: Adults encoding negative pictures
Number of subjects: 30
Study 18324566 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking Reduction (SR)
Number of subjects: 152
Study 18324566 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 152
Study 18324566 — intervention group
Group type: EXPERIMENTAL
Intervention: All subjects (regardless of treatment condition)
Number of subjects: 152
Study 15944869 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg o. d. for 3 months
Number of subjects: 0
Study 15944869 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 0
Study 15944869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15944869 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive treatment
Number of subjects: 0
Study 12886917 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (0.1 mg x kg‐1)
Number of subjects: 150
Study 12886917 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclizine (20 mg)
Number of subjects: 150
Study 12886917 — intervention group
Group type: COMPARATOR
Intervention: placebo (normal saline)
Number of subjects: 150
Study 10391662 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL-raising therapy
Number of subjects: 2531
Study 10391662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2531
Study 8872291 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with 1-lb walking poles
Number of subjects: 0
Study 8872291 — intervention group
Group type: COMPARATOR
Intervention: Walking without poles
Number of subjects: 0
Study 1997698 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bacillus Calmette-Guerin (BCG)
Number of subjects: 71
Study 1997698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette-Guerin (BCG)
Number of subjects: 71
Study 1997698 — intervention group
Group type: COMPARATOR
Intervention: Control group (transurethral resection only)
Number of subjects: 71
Study 1997698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical BCG
Number of subjects: 71
Study 1997698 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral BCG
Number of subjects: 71
Study 6206321 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tocainide
Number of subjects: 10
Study 6206321 — intervention group
Group type: COMPARATOR
Intervention: Disopyramide
Number of subjects: 10
Study 30755104 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking status
Number of subjects: 282
Study 30755104 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 282
Study 30755104 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer diabetes duration
Number of subjects: 282
Study 30755104 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher diabetes-related distress
Number of subjects: 282
Study 29489859 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollients
Number of subjects: 23
Study 29489859 — intervention group
Group type: COMPARATOR
Intervention: Control (no emollients)
Number of subjects: 23
Study 27030325 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide 4 mg/day
Number of subjects: 78
Study 27030325 — intervention group
Group type: COMPARATOR
Intervention: Intravenous prednisolone
Number of subjects: 78
Study 25351025 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based communication (SG)
Number of subjects: 500
Study 25351025 — intervention group
Group type: COMPARATOR
Intervention: Traditional communication (CG)
Number of subjects: 500
Study 22534712 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy methods applied during a monthly rehabilitation tour
Number of subjects: 40
Study 22534712 — intervention group
Group type: COMPARATOR
Intervention: Physical methods of treatment
Number of subjects: 40
Study 20367417 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose teriparatide (20 microg per day)
Number of subjects: 27
Study 20367417 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose teriparatide (40 microg per day)
Number of subjects: 27
Study 20367417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 17995993 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letters
Number of subjects: 1499
Study 17995993 — intervention group
Group type: EXPERIMENTAL
Intervention: Practitioner-delivered brief advice
Number of subjects: 1499
Study 17995993 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 1499
Study 15989909 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 5477
Study 15989909 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 5477
Study 12027474 — intervention group
Group type: EXPERIMENTAL
Intervention: haemodynamic optimisation through the use of a pulmonary artery catheter
Number of subjects: 100
Study 12027474 — intervention group
Group type: COMPARATOR
Intervention: conventional treatment
Number of subjects: 100
Study 10348394 — intervention group
Group type: EXPERIMENTAL
Intervention: Shah, Vanclay and Cooper's modified Barthel Index
Number of subjects: 100
Study 10348394 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking speed over 10 metres
Number of subjects: 100
Study 8551532 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous vocalization for 30 minutes after botulinum toxin injections
Number of subjects: 20
Study 8551532 — intervention group
Group type: COMPARATOR
Intervention: Vocal rest for 30 minutes after botulinum toxin injections
Number of subjects: 20
Study 1685447 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg three times daily)
Number of subjects: 12
Study 1685447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7199332 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.2 mg/kg)
Number of subjects: 43
Study 7199332 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (0.3 mg/kg)
Number of subjects: 43
Study 30045355 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal Ketamine (1 mg/kg)
Number of subjects: 22
Study 30045355 — intervention group
Group type: COMPARATOR
Intervention: Intranasal Fentanyl (1.5 μg/kg)
Number of subjects: 22
Study 31613881 — intervention group
Group type: EXPERIMENTAL
Intervention: Transactional sex participation in the past three months
Number of subjects: 600
Study 31613881 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use with non-paying partners
Number of subjects: 600
Study 31613881 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced alcohol use at work
Number of subjects: 600
Study 31613881 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern contraception use
Number of subjects: 600
Study 31613881 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiences of gender-based violence
Number of subjects: 600
Study 29413434 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg, twice daily
Number of subjects: 302
Study 26126158 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic steering and automated lumen centralization (RS-ALC)
Number of subjects: 18
Study 26126158 — intervention group
Group type: COMPARATOR
Intervention: Conventional steering
Number of subjects: 18
Study 25151662 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment interventions
Number of subjects: 272
Study 22583627 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrapatellar fat pad-derived mesenchymal stem cell therapy combined with arthroscopic debridement and PRP injection
Number of subjects: 25
Study 22583627 — intervention group
Group type: COMPARATOR
Intervention: Control group (arthroscopic debridement and PRP injection without stem cells)
Number of subjects: 25
Study 19915976 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal treatment for metastatic disease: yes
Number of subjects: 1361
Study 19915976 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxanes at first line: yes
Number of subjects: 1361
Study 19915976 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab at first line: yes
Number of subjects: 1361
Study 19915976 — intervention group
Group type: COMPARATOR
Intervention: Time period 1995-1998
Number of subjects: 1361
Study 19915976 — intervention group
Group type: COMPARATOR
Intervention: Time period 1999-2002
Number of subjects: 1361
Study 19915976 — intervention group
Group type: COMPARATOR
Intervention: Time period 2003-2006
Number of subjects: 1361
Study 18555828 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT+)
Number of subjects: 206
Study 18555828 — intervention group
Group type: COMPARATOR
Intervention: No Hormone Replacement Therapy (HRT-)
Number of subjects: 206
Study 18555828 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 206
Study 16866128 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic appliances
Number of subjects: 0
Study 16866128 — intervention group
Group type: COMPARATOR
Intervention: Control groups receiving appropriate treatment
Number of subjects: 0
Study 12627926 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 2 g in 50 ml of 0.9% sodium chloride
Number of subjects: 20
Study 12627926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20